Cytokine profiles in serum of patients with oral lichen planus

Cytokine

Volumn 60, Issue 3, 2012, Pages 701-706

  Pekiner, Filiz Namdar ^a   Demirel, Gülderen Yanikkaya ^b   Borahan, Mehmet Oguz ^a   Özbayrak, Semih ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Cytokine; Oral lichen planus; T helper 1; T helper 2

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; LICHEN PLANUS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TH1 CELL; TH2 CELL;

CYTOKINES; FEMALE; HUMANS; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; TH1 CELLS; TH1-TH2 BALANCE; TH2 CELLS;

EID: 84867993291     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.08.007     Document Type: Article

References (41)

1. Liu G.X., Sun J.T., Yang M.X., Qi X.M., Shao Q.Q., Xie Q, et al. OPN promotes survival of activated T cells by up-regulating CD44 in patients with oral lichen planus. Clin Immunol 2011, 138:291-298.
2. Roopashree M.R., Gondhalekar R.V., Shashikanth, Geroge J., Thippeswamy S.H. Pathogenesis of oral lichen planus-a review. J Oral Pathol Med 2010, 39:729-734.
3. Khan A., Farah C.S., Savage N.W., Walsh L.J., Harbrow D.J., Sugerman P.B. Th1 cytokines in oral lichen planus. J Oral Pathol Med 2003, 32:77-83.
4. Pimentel V.N., de Matos L.S., Soares T.C.B., Adam R., Metze K., Correa M.E.P., et al. Perforin and granzyme B involvement in oral lesions of lichen planus and chronic GVHD. J Oral Pathol Med 2010, 39:741-746.
5. Sugerman P.B., Savage N.W., Walsh L.J., Zhao Z.Z., Zhou X.J., Khan A., et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002, 13:350-365.
6. Zhou Z.T., Wei B.J., Shi P. Osteopontin expression in oral lichen planus. J Oral Pathol Med 2008, 37:94-98.
7. Cortes-Ramirez D.A., Gainza-Cirauqui M.L., Echebarria-Goikouria M.A., Aguirre-Urizar J.M. Oral lichenoid disease as a premaglinant condition: the controversies and the unknown. Med Oral Pathol Oral Cir Bucal 2009, 14:E118-E122.
8. Porter S.R., Kirby A., Olsen I., Barret W. Immunologic aspects of dermal and oral lichen planus: a review. Oral Med Oral Pathol Oral Radiol Endod 1997, 83:358-366.
9. Mattila R., Ahlfors E., Syrjanen S. CD27 and CD38 lymphocytes are detected in oral lichen planus lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011, 111:211-217.
10. Rhodus N.L., Cheng B., Ondrey F. Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus. Mediat Inflamm 2007, 2007. 19854. 10.1155/2007/19854.
11. Rengarajan J., Szabo S.J., Glimcher L.H. Transcriptional regulation of Th1/Th2 polarization. Immunol Today 2000, 21:479-483.
12. Gor D.O., Rose N.R., Greenspan N.S. TH1-TH2: a procrustean paradigm. Nat Immunol 2003, 4:503-505.
13. Hamzaoui K., Hamzaoui A., Guemira F., Bessioud M., Hamza M., Ayed K. Cytokine profile in BehÇet's disease patients: relationship with disease activity. Scand J Rheumatol 2002, 31:56-63.
14. Sklavounou A., Chrysomali E., Scorilas A., Karameris A. TNF-α expression and apoptosisregulating proteins in oral lichen planus: a comparative immunohistochemical evaluation. J Oral Pathol Med 2000, 29:370-375.
15. Pezelj-Ribaric S., Prso I.B., Abram M., Glazar I., Brumini G., Simunovic-Soskic Salivary levels of tumor necrosis factor-α in oral lichen planus. Mediat Inflamm 2004, 13:131-133.
16. Ghallab N.A., El-Wakeel N., Shaker O. Levels of salivary IFN-gamma, TNF-Alfa, and TNF Receptor-2 as prognostic markers in (erosive) oral lichen planus. Mediat Inflamm 2010, 847632. 10.1155/2010/84763.
17. Zhou G., Xia K., Du G.F., Cheng X.M., Xu X.Y., Lu R., et al. Activation of nuclear factor-kappa B correlates with tumor necrosis factor-alpha in oral lichen planus: a clinicopathologic study in atrophic-erosive and reticular form. J Oral Pathol Med 2009, 38:559-564.
18. Liu W., Dan H., Wang Z., Jiang L., Zhou Y., Zhao M., et al. IFN-Gamma and IL-4 in saliva of patients with oral lichen planus: a study in an ethnic Chinese population. Inflammation 2009, 32:176-181.
19. Yamamoto T., Yoneda K., Ueta E., Osaki T. Serum cytokines, interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in oral disorders. Oral Surg Oral Med Oral Pathol 1994, 78:727-735.
20. Kalgerakou F., Albanidou-Farmaki E., Markopoulus A.K., Antoniades D.Z. Detection of T cells secreting type 1 and type 2 cytokines in the peripheral blood of patients with oral lichen planus. Hippokratia 2008, 12:230-235.
21. Karagouni E., Dotsika E., Sklavounou A. Alteration in peripheral blood mononuclear cell function and serum cytokines in oral lichen planus. J Oral Pathol Med 1994, 23:28-35.
22. Yamamoto T., Osaki T. Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus. J Invest Dermatol 1995, 104:784-788.
23. Zhang Y., Liu W., Zhang S., Dan H., Lu R., Wang F., et al. Salivary and serum interleukin-18 in patients with oral lichen planus: a study in an ethnic Chinese population. Inflammation 2011, [Epub ahead of print]. 10.1007/s10753-011-9327-3.
24. Rhodus N.L., Cheng B., Myers S., Bowles W., Ho V., Ondrey F. A comparison of the pro-inflammatory, NF-kappaB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clin Immunol 2005, 114:278-283.
25. Beadling C., Johnson K.W., Smith K.A. Isolation of interleukin 2-induced immediate-early genes. Proc Nat Acad Sci 1993, 90:2719-2723.
26. Beadling C.B., Smith K.A. DNA array analysis of interleukin-2-regulated immediate/early genes. Med Immunol 2002, 1:2.
27. Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains. Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 155:1151-1164.
28. Simark-Mattsson C., Bergenholtz G., Jontell M., Eklund C., Seymour G.J., Sugerman P.B., et al. Distribution of interleukin-2, -4, -10, tumour necrosis factor-alpha and transforming growth factor-beta m-RNAs in oral lichen planus. Arch Oral Biol 1999, 44:499-507.
29. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991, 147:3815-3822.
30. Asadullah K., Sterry W., Volk H.D. Interleukin-10 therapy-review of a new approach. Pharmacol Rev 2003, 55:241-269.
31. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765.
32. Groux H., Cottrez F. The complex role of interleukin-10 in autoimmunity. J Autoimmun 2003, 20:281-285.
33. Dan H., Liu W., Wang J., Wang Z., Wu R., Chen Q., et al. Elevated IL-10 concentrations in serum and saliva from patients with oral lichen planus. Quintessence Int 2011, 42:157-163.
34. Del Prete G., De Carli M., Almerigogna F., Giudizi M.G., Biagiotti R., Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993, 150:353-360.
35. Bai J.P., Lin M., Zeng X., et al. Association of polymorphisms in the human IFN-gamma and IL-4 gene with oral lichen planus: a study in an ethnic Chinese cohort. J Interferon Cytok Res 2008, 28:351-358.
36. Al-Hashimi I., Schifter M., Lockhart P.B., et al. Oral mlichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 103:25-31.
37. Romagnani S. Biology of human TH1 and TH2 cells. J Clin Immunol 1995, 15:121-129.
38. Couper K.N., Blount D.G., Riley E.M. IL-10:The master regulator of immunity to infection. J Immunol 2008, 180:5771-5777.
39. Nemunaitis J., Fong T., Shabe P., Martineau D., Ando D. Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma. Cancer Invest 2001, 19:239-247.
40. Kohyama M., Sugahara D., Sugiyama S., Yagita H., Okumura K., Hozum N. Inducible costimulator-dependent IL-10 production by regulatory T cells specific for self-antigen. PNAS 2004, 101:4192-4197.
41. Ukichi K., Okamura T., Fukushima D., Morimoto M., Yamane G., Takahashi S. Th1/Th2 balance in mouse delayed type hypersensitivity model with mercuric chloride via skin and oral mucosa. Bull Tokyo Dent Coll 2011, 52:13-20.